132 related articles for article (PubMed ID: 18450737)
41. Primary duodenal lymphoma: successful rituximab treatment and evaluation by FDG-PET.
Tanaka F; Tominaga K; Ochi M; Yamada T; Sasaki E; Shiba M; Watanabe T; Fujiwara Y; Uchida T; Oshitani N; Higuchi K; Arakawa T
Hepatogastroenterology; 2007 Sep; 54(78):1658-61. PubMed ID: 18019688
[TBL] [Abstract][Full Text] [Related]
42. Incidental findings on follow-up fluorodeoxyglucose positron emission tomography studies in lymphoma patients: beware the outlier.
Aide N; Irving L; Hicks RJ
Leuk Lymphoma; 2009 Jun; 50(6):865-7. PubMed ID: 19504393
[No Abstract] [Full Text] [Related]
43. Does health economics have an impact on non-Hodgkin's lymphoma patients' options?
Otte A
Nucl Med Commun; 2008 Aug; 29(8):748-9. PubMed ID: 18753830
[No Abstract] [Full Text] [Related]
44. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Bennett M; Yegena S; Dave HP; Schechter GP
Hematol Oncol; 2008 Jun; 26(2):114. PubMed ID: 18271062
[No Abstract] [Full Text] [Related]
45. Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2006 Nov; 91(11):1453-5. PubMed ID: 17082005
[No Abstract] [Full Text] [Related]
46. Rituximab-induced pneumonitis on F-18 FDG PET/CT in patient with non-Hodgkin lymphoma.
Song BI; Lee SW; Lee HJ; Kang S; Jeong SY; Seo JH; Ahn BC; Lee J; Shin KM
Clin Nucl Med; 2010 Aug; 35(8):601-3. PubMed ID: 20631510
[No Abstract] [Full Text] [Related]
47. Monoclonal antibody therapy for indolent lymphomas.
Grossbard ML; Nadler LM
Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
[No Abstract] [Full Text] [Related]
48. Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy.
Perrotti AP; Niscola P; Boemi S; Scaramucci L; Dentamaro T; Palombi M; Ales M; Cupelli L; Tendas A; Piccioni D; Giovannini M; Naso V; Martelli M; de Fabritiis P
Tumori; 2009; 95(1):129-30. PubMed ID: 19366073
[No Abstract] [Full Text] [Related]
49. Radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.
Kaminski MS; Armitage JO
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-54-8. PubMed ID: 23570101
[No Abstract] [Full Text] [Related]
50. Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
Appelbaum FR
Hematol Oncol Clin North Am; 1991 Oct; 5(5):1013-25. PubMed ID: 1938754
[TBL] [Abstract][Full Text] [Related]
51. Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma.
Eary JF; Krohn KA; Press OW; Durack L; Bernstein ID
Nucl Med Biol; 1997 Oct; 24(7):635-8. PubMed ID: 9352534
[TBL] [Abstract][Full Text] [Related]
52. A patient with endobronchial BALT lymphoma successfully treated with radiotherapy.
Hashemi SM; Heitbrink MA; Jiwa M; Boersma WG
Respir Med; 2007 Oct; 101(10):2227-9. PubMed ID: 17616383
[TBL] [Abstract][Full Text] [Related]
53. Low-grade lymphomas.
Grünwald HW
Cancer Invest; 1999; 17(1):93. PubMed ID: 10999053
[No Abstract] [Full Text] [Related]
54. Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab.
Rossi D; Ramponi A; Franceschetti S; Stratta P; Gaidano G
Leuk Res; 2008 May; 32(5):829-34. PubMed ID: 18036657
[TBL] [Abstract][Full Text] [Related]
55. Recurrent indolent NHL: new strategies for treatment.
Amen K
ONS Connect; 2007; 22(8 Suppl):57-8. PubMed ID: 17824567
[No Abstract] [Full Text] [Related]
56. Update on epidemiology and therapeutics for non-Hodgkin's lymphoma.
Vose JM; Chiu BC; Cheson BD; Dancey J; Wright J
Hematology Am Soc Hematol Educ Program; 2002; ():241-62. PubMed ID: 12446426
[TBL] [Abstract][Full Text] [Related]
57. Targeted treatment for non-Hodgkin's lymphoma.
Health News; 2002 May; 8(5):7. PubMed ID: 12132412
[No Abstract] [Full Text] [Related]
58. Immuno-PET Imaging and Radioimmunotherapy of Lymphomas.
Lee KH; Jung KH; Lee JH
Mol Pharm; 2022 Oct; 19(10):3484-3491. PubMed ID: 36046954
[TBL] [Abstract][Full Text] [Related]
59. New treatment may eradicate virulent lymphoma. A single course of infections kills cancers, with minimal side-effects; positive responses immediate.
Health News; 2005 May; 11(5):6-8. PubMed ID: 15887314
[No Abstract] [Full Text] [Related]
60. Radioimmunotherapy for non-Hodgkin's lymphoma.
Friedberg JW
Clin Cancer Res; 2004 Dec; 10(23):7789-91. PubMed ID: 15585609
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
